Tackling oxaliplatin drug resistance in colorectal cancer by developing a novel bifunctional prodrug
University of Bradford
Faculty of Life Sciences
Research Group:
Institute of Cancer Therapeutics
Acquired drug resistance is a considerable problem for the treatment of colorectal cancer (CRC), of which oxaliplatin is a key component, with little improvement in the ~65% 5-year survival rate over the past 25 years. Read more
Supervisors: Dr S Shnyder, Dr G Ribeiro Morais, Prof R Falconer
Year round applications
PhD Research Project
Self-Funded PhD Students Only